Mitchell E. Levinson net worth and biography

Mitchell Levinson Biography and Net Worth

Insider of Pulse Biosciences

Mitchell E. Levinson joined as Chief Strategy Officer of Pulse Biosciences in August 2021 and continues in his role on our Board of Directors. Mr. Levinson served on the board from January 2015 to November 2017 and then returned March 2019 to May 2023. Mr. Levinson has over 30 years of experience developing and launching novel medical device technologies across multiple medical disciplines, including dermatology, wound care, surgery, diagnostics, otolaryngology, microbiology, neurology, OB/GYN, patient monitoring and digital health. Most recently, he co-founded and served as startup CEO for Cerebrotech Medical Systems where he led the development of a novel brain monitor. Mr. Levinson was the first employee and startup CEO for Zeltiq Aesthetics, the CoolSculpting company, acquired by Allergan in 2017. Prior to Zeltiq, he held executive R&D positions at Thermage and BioSurgical Corporation. Mr. Levinson currently sits on the boards of directors for several medical technology startup companies. He is an inventor on over 50 issued and numerous pending U.S. patents. Mr. Levinson earned his B.S. in Mechanical Engineering from University of California at San Diego and holds an M.S. in Computer Systems from the University of Phoenix.

What is Mitchell E. Levinson's net worth?: The estimated net worth of Mitchell E. Levinson is at least $1.15 million as of November 15th, 2023. Mr. Levinson owns 73,027 shares of Pulse Biosciences stock worth more than $1,150,832 as of April 7th. This net worth estimate does not reflect any other assets that Mr. Levinson may own. Learn More about Mitchell E. Levinson's net worth.
How do I contact Mitchell E. Levinson?: The corporate mailing address for Mr. Levinson and other Pulse Biosciences executives is 3957 POINT EDEN WAY, HAYWARD CA, 94545. Pulse Biosciences can also be reached via phone at (510) 906-4600 and via email at ir@pulsebiosciences.com. Learn More on Mitchell E. Levinson's contact information.
Has Mitchell E. Levinson been buying or selling shares of Pulse Biosciences?: Mitchell E. Levinson has not been actively trading shares of Pulse Biosciences in the last ninety days. Most recently, on Wednesday, November 15th, Mitchell E. Levinson bought 4,261 shares of Pulse Biosciences stock. The stock was acquired at an average cost of $5.87 per share, with a total value of $25,012.07. Following the completion of the transaction, the insider now directly owns 73,027 shares of the company's stock, valued at $428,668.49. Learn More on Mitchell E. Levinson's trading history.
Who are Pulse Biosciences' active insiders?: Pulse Biosciences' insider roster includes Kevin Danahy (CEO), Robert Duggan (Co-Chairman of the Board of Directors), Mitchell Levinson (Insider), and Mitchell Levinson (Insider). Learn More on Pulse Biosciences' active insiders.
Are insiders buying or selling shares of Pulse Biosciences?: In the last twelve months, Pulse Biosciences insiders bought shares 3 times. They purchased a total of 121,310 shares worth more than $2,007,434.98. In the last twelve months, insiders at the sold shares 1 times. They sold a total of 50,000 shares worth more than $871,000.00. The most recent insider tranaction occured on December, 13th when Director Robert W Duggan bought 55,256 shares worth more than $949,298.08. Insiders at Pulse Biosciences own 71.5% of the company. Learn More about insider trades at Pulse Biosciences.
Information on this page was last updated on 12/13/2024.

Mitchell E. Levinson Insider Trading History at Pulse Biosciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/15/2023	Buy	4,261	$5.87	$25,012.07	73,027
10/7/2022	Buy	8,770	$2.29	$20,083.30	46,274
9/14/2017	Buy	3,835	$12.30	$47,170.50

Mitchell E. Levinson Buying and Selling Activity at Pulse Biosciences

Pulse Biosciences Company Overview

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Today's Range

Now: $15.76

$13.80

$15.01

50 Day Range

MA: $18.54

$14.53

$24.56

2 Week Range

Now: $15.76

$6.60

$25.00

Volume

11,078 shs

Average Volume

197,021 shs

Market Capitalization

$1.06 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.87